文献速递肝胆胰外科围术期管理与 ERAS

全胰腺切除联合自体胰岛移植作为胰十二指肠切除术后高危胰肠吻合的替代方案:一项前瞻性随机试验

Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial.
PubMed 文献 · Ann Surg · 2022-09-30

OBJECTIVE: To compare pancreaticoduodenectomy (PD) and total pancreatectomy (TP) with islet autotransplantation (IAT) in patients at high risk of postoperative pancreatic fistula (POPF). BACKGROUND: Criteria to predict the risk of POPF occurrence after PD are available.…

要点

  • 高危胰瘘患者中TP-IAT较PD显著降低90天并发症发生率。
  • TP-IAT组术后住院时间更短,但糖尿病风险显著增加。
  • 两组无病生存、复发部位及总生存无差异。

核心结论

  • 对于预测高胰瘘风险的PD候选者,TP-IAT可能成为标准治疗。

研究设计与样本

  • 随机、开放标签、对照、双中心试验(NCT01346098),纳入2010至2019年61例高危胰腺吻合(软胰腺且胰管直径≤3 mm)的PD候选者,1:1随机分配至PD组(n=31)或TP-IAT组(n=30)。

主要发现

  • PD组发生≥2级并发症的风险增加(OR=7.64,95%CI 1.35-43.3,P=0.022),≥3级并发症OR=2.82(95%CI 0.86-9.24,P=0.086)。
  • TP-IAT组术后住院时间更短(中位数10.5 vs 16.0天,P<0.001)。
  • 两组无病生存、复发部位、疾病特异性生存和总生存无差异。
  • TP-IAT与更高的糖尿病风险相关(HR=9.1,95%CI 3.76-21.9,P<0.0001),但多数患者代谢控制良好且C肽持续产生。

临床怎么用

  • 对于软胰腺且胰管直径≤3 mm的高危POPF患者,可考虑TP-IAT作为PD的替代方案,但需权衡糖尿病风险。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

OBJECTIVE: To compare pancreaticoduodenectomy (PD) and total pancreatectomy (TP) with islet autotransplantation (IAT) in patients at high risk of postoperative pancreatic fistula (POPF). BACKGROUND: Criteria to predict the risk of POPF occurrence after PD are available. However, even when a high risk of POPF is predicted, TP is not currently accepted as an alternative to PD, because of its severe consequences on glycaemic control. Combining IAT with TP may mitigate such consequences. METHODS: Randomized, open-label, controlled, bicentric trial (NCT01346098). Candidates for PD at high-risk pancreatic anastomosis (ie, soft pancreas and duct diameter ≤3 mm) were randomly assigned (1:1) to undergo either PD or TP-IAT. The primary endpoint was the incidence of complications within 90 days after surgery. RESULTS: Between 2010 and 2019, 61 patients were assigned to PD (n=31) or TP-IAT (n=30). In the intention-to-treat analysis, morbidity rate was 90·3% after PD and 60% after TP-IAT ( P =0.008). According to complications' severity, PD was associated with an increased risk of grade ≥2 [odds ratio (OR)=7.64 (95% CI: 1.35-43.3), P =0.022], while the OR for grade ≥3 complications was 2.82 (95% CI: 0.86-9.24, P =0.086). After TP-IAT, the postoperative stay was shorter [median: 10.5 vs 16.0 days; P <0.001). No differences were observed in disease-free survival, site of recurrence, disease-specific survival, and overall survival. TP-IAT was associated with a higher risk of diabetes [hazard ratio=9.1 (95% CI: 3.76-21.9), P <0.0001], but most patients maintained good metabolic control and showed sustained C-peptide production over time. CONCLUSIONS: TP-IAT may become the standard treatment in candidates for PD, when a high risk of POPF is predicted.

来源:Ann Surg,查看原文。版权归原作者所有。

引用

  1. Balzano G, Zerbi A, Aleotti F, et al. Total Pancreatectomy With Islet Autotransplantation as an Alternative to High-risk Pancreatojejunostomy After Pancreaticoduodenectomy: A Prospective Randomized Trial. Ann Surg. 2022. PMID: 36177837. doi:10.1097/SLA.0000000000005713

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。